Although PTH (1-84) therapy has obtained a significant reduction in the need for calcium and active vitamin D supplementation, once-daily administration is not effective in reducing the incidence of hypercalcemia, hypocalcemia, hypercalciuria, and hyperphosphatemia. The gene discussed is PTH; the disease is Hypercalciuria.